Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
After salvage radiation and hormone therapy for prostate cancer, blogger Daniel Zeller learned his PSA nearly doubled.
After completing salvage radiation and androgen deprivation therapies for prostate cancer, Daniel Zeller looks at his PSA numbers.
Do the androgen deprivation therapy effects of prostate cancer treatment wear off faster than the salvage radiation effects kick in?
After 15 years, survival rates were similar for patients who were treated promptly and those who received active monitoring.
Blogger Daniel Zeller makes assessments after completing salvage radiation and hormone therapies for his prostate cancer.
Melanoma, a potentially deadly type of skin cancer, is often more fatal in men than women. Androgen receptors may play a role.
People with prostate cancer who received hormone therapy plus pelvic lymph node treatment experienced an average five-year survival of 87%.
A large clinical trial found that adding darolutamide to two other therapies increased survival for people with advanced prostate cancer.
In a nutshell, he suggested doing concurrent androgen deprivation (hormone) therapy with the salvage radiation.
Study finds bone health testing for patients with prostate cancer undergoing ADT therapy are not meeting guideline recommendations.
The androgen receptor inhibitor delayed cancer metastasis in a late-stage clinical trial.
The American Society of Clinical Oncology has released new prostate cancer guidelines.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.